| European Case Law Identifier: | ECLI:EP:BA:2002:T091302.20021218 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 18 December 2002 | ||||||||
| Case number: | T 0913/02 | ||||||||
| Application number: | 98938676.8 | ||||||||
| IPC class: | A61N 1/32 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo | ||||||||
| Applicant name: | Aventis Pharma., et al | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.4.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | No statement of grounds | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Summary of Facts and Submissions
1. The appeal contests the decision of the Examining Division of the European Patent Office dated 22 March 2002 refusing the European patent application No. 98 938 676.8. The appellant filed a notice of appeal by a letter received on 23 May 2002 and paid the fee on the same day. No Statement of Grounds was filed. The notice of appeal contains nothing that could be regarded as a Statement of Grounds pursuant to Article 108 EPC.
2. By a communication dated 4 October 2002 sent by registered letter with advice of delivery, the Registry of the Board informed the appellant that no Statement of Grounds had been filed and that the appeal could be expected to be rejected as inadmissible. The appellant was invited to file observations within two months.
3. No answer has been given to the Registry's communication.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed, the appeal has to be rejected as inadmissible (Article 108 EPC in conjunction with Rule 65(1) EPC).
ORDER
For these reasons, it is decided that:
The appeal is rejected as inadmissible.
